| Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment J Fang, L Wang, T Wu, C Yang, L Gao, H Cai, J Liu, S Fang, Y Chen, ... Journal of ethnopharmacology 196, 281-292, 2017 | 116 | 2017 |
| Discovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformations L Wang, Q Gu, X Zheng, J Ye, Z Liu, J Li, X Hu, A Hagler, J Xu Journal of chemical information and modeling 53 (9), 2409-2422, 2013 | 72 | 2013 |
| Salvianolic acid A, a polyphenolic derivative from Salvia miltiorrhiza bunge, as a multifunctional agent for the treatment of Alzheimer’s disease YY Cao, L Wang, H Ge, XL Lu, Z Pei, Q Gu, J Xu Molecular diversity 17 (3), 515-524, 2013 | 67 | 2013 |
| Syringic acid extracted from Herba dendrobii prevents diabetic cataract pathogenesis by inhibiting aldose reductase activity X Wei, D Chen, Y Yi, H Qi, X Gao, H Fang, Q Gu, L Wang, L Gu Evidence-Based Complementary and Alternative Medicine 2012, 2012 | 60 | 2012 |
| Design, synthesis, biological evaluation, and molecular modeling studies of chalcone-rivastigmine hybrids as cholinesterase inhibitors L Wang, Y Wang, Y Tian, J Shang, X Sun, H Chen, H Wang, W Tan Bioorganic & Medicinal Chemistry 25 (1), 360-371, 2017 | 58 | 2017 |
| Antiviral activity of (+)-rutamarin against Kaposi's sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II B Xu, L Wang, L González-Molleda, Y Wang, J Xu, Y Yuan Antimicrobial agents and chemotherapy 58 (1), 563-573, 2014 | 49 | 2014 |
| FP-GNN: a versatile deep learning architecture for enhanced molecular property prediction H Cai, H Zhang, D Zhao, J Wu, L Wang Briefings in Bioinformatics, 1-12, 2022 | 47 | 2022 |
| Discovering New Agents Active against Methicillin-Resistant Staphylococcus aureus with Ligand-Based Approaches L Wang, X Le, L Li, Y Ju, Z Lin, Q Gu, J Xu Journal of chemical information and modeling 54 (11), 3186-3197, 2014 | 46 | 2014 |
| Discovering new mTOR inhibitors for cancer treatment through virtual screening methods and in vitro assays L Wang, L Chen, M Yu, LH Xu, B Cheng, YS Lin, Q Gu, XH He, J Xu Scientific reports 6 (1), 18987, 2016 | 44 | 2016 |
| 3,5-Diarylpyrazole Derivatives Obtained by Ammonolysis of the Total Flavonoids from Chrysanthemum indicum Extract Show Potential for the Treatment of … T Wu, C Jiang, L Wang, SL Morris-Natschke, H Miao, L Gu, J Xu, KH Lee, ... Journal of natural products 78 (7), 1593-1599, 2015 | 42 | 2015 |
| The mechanisms of flavonoids inhibiting conformational transition of amyloid-β 42 monomer: a comparative molecular dynamics simulation study L Wang, R Zeng, X Pang, Q Gu, W Tan RSC advances 5 (81), 66391-66402, 2015 | 39 | 2015 |
| Structure activity related, mechanistic, and modeling studies of gallotannins containing a glucitol-core and α-glucosidase H Ma, L Wang, DB Niesen, A Cai, BP Cho, W Tan, Q Gu, J Xu, NP Seeram RSC advances 5 (130), 107904-107915, 2015 | 38 | 2015 |
| Synthesis and characterization of 1H-phenanthro [9, 10-d] imidazole derivatives as multifunctional agents for treatment of Alzheimer's disease J Liu, J Qiu, M Wang, L Wang, L Su, J Gao, Q Gu, J Xu, SL Huang, LQ Gu, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1840 (9), 2886-2903, 2014 | 38 | 2014 |
| RADER: a RApid DEcoy Retriever to facilitate decoy based assessment of virtual screening L Wang, X Pang, Y Li, Z Zhang, W Tan Bioinformatics 33 (8), 1235-1237, 2017 | 37 | 2017 |
| Predicting mTOR inhibitors with a classifier using recursive partitioning and naive Bayesian approaches L Wang, L Chen, Z Liu, M Zheng, Q Gu, J Xu PLoS One 9 (5), e95221, 2014 | 37 | 2014 |
| Cosmetic applications of glucitol-core containing gallotannins from a proprietary phenolic-enriched red maple (Acer rubrum) leaves extract: inhibition of … H Ma, J Xu, NA DaSilva, L Wang, Z Wei, L Guo, SL Johnson, W Lu, J Xu, ... Archives of dermatological research 309, 265-274, 2017 | 35 | 2017 |
| The hydrolyzable gallotannin, penta-O-galloyl-β-d-glucopyranoside, inhibits the formation of advanced glycation endproducts by protecting protein structure H Ma, W Liu, L Frost, L Wang, L Kong, JA Dain, NP Seeram Molecular BioSystems 11 (5), 1338-1347, 2015 | 35 | 2015 |
| Targeting the PI3K/AKT/mTOR signaling pathway in the treatment of human diseases: Current status, trends, and solutions J Huang, L Chen, J Wu, D Ai, JQ Zhang, TG Chen, L Wang Journal of medicinal chemistry 65 (24), 16033-16061, 2022 | 34 | 2022 |
| Three-dimensional pharmacophore modeling of liver-X receptor agonists W Zhao, Q Gu, L Wang, H Ge, J Li, J Xu Journal of chemical information and modeling 51 (9), 2147-2155, 2011 | 34 | 2011 |
| Design, synthesis and bioevaluation of novel substituted triazines as potential dual PI3K/mTOR inhibitors TT Wu, QQ Guo, ZL Chen, LL Wang, Y Du, R Chen, YH Mao, SG Yang, ... European Journal of Medicinal Chemistry 204, 112637, 2020 | 33 | 2020 |
Qiong GuSchool of Pharmaceutical Sciences, Sun Yat-Sen UniversityVerified email at mail.sysu.edu.cn
